318 related articles for article (PubMed ID: 1713603)
1. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location.
Harper K; Balzano C; Rouvier E; Mattéi MG; Luciani MF; Golstein P
J Immunol; 1991 Aug; 147(3):1037-44. PubMed ID: 1713603
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 and CD28: similar proteins, neighbouring genes.
Balzano C; Buonavista N; Rouvier E; Golstein P
Int J Cancer Suppl; 1992; 7():28-32. PubMed ID: 1330947
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
4. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches.
Ling V; Wu PW; Finnerty HF; Agostino MJ; Graham JR; Chen S; Jussiff JM; Fisk GJ; Miller CP; Collins M
Genomics; 2001 Dec; 78(3):155-68. PubMed ID: 11735222
[TBL] [Abstract][Full Text] [Related]
5. The genomic organization of the CD28 gene. Implications for the regulation of CD28 mRNA expression and heterogeneity.
Lee KP; Taylor C; Petryniak B; Turka LA; June CH; Thompson CB
J Immunol; 1990 Jul; 145(1):344-52. PubMed ID: 2162892
[TBL] [Abstract][Full Text] [Related]
6. Characterization of CTLA-4 structure and expression on human T cells.
Lindsten T; Lee KP; Harris ES; Petryniak B; Craighead N; Reynolds PJ; Lombard DB; Freeman GJ; Nadler LM; Gray GS
J Immunol; 1993 Oct; 151(7):3489-99. PubMed ID: 8397258
[TBL] [Abstract][Full Text] [Related]
7. Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.
Ling V; Wu PW; Finnerty HF; Sharpe AH; Gray GS; Collins M
Genomics; 1999 Sep; 60(3):341-55. PubMed ID: 10493833
[TBL] [Abstract][Full Text] [Related]
8. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.
Tezuka K; Tsuji T; Hirano D; Tamatani T; Sakamaki K; Kobayashi Y; Kamada M
Biochem Biophys Res Commun; 2000 Sep; 276(1):335-45. PubMed ID: 11006126
[TBL] [Abstract][Full Text] [Related]
10. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression.
Gross JA; St John T; Allison JP
J Immunol; 1990 Apr; 144(8):3201-10. PubMed ID: 2157764
[TBL] [Abstract][Full Text] [Related]
11. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with type 1 diabetes in the Japanese population.
Ihara K; Ahmed S; Nakao F; Kinukawa N; Kuromaru R; Matsuura N; Iwata I; Nagafuchi S; Kohno H; Miyako K; Hara T
Immunogenetics; 2001 Aug; 53(6):447-54. PubMed ID: 11685455
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Kosmaczewska A; Ciszak L; Boćko D; Frydecka I
Arch Immunol Ther Exp (Warsz); 2001; 49(1):39-46. PubMed ID: 11266089
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism of the human ICOS gene.
Haimila KE; Partanen JA; Holopainen PM
Immunogenetics; 2002 Mar; 53(12):1028-32. PubMed ID: 11904679
[TBL] [Abstract][Full Text] [Related]
14. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.
Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW
J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461
[TBL] [Abstract][Full Text] [Related]
15. B70 antigen is a second ligand for CTLA-4 and CD28.
Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
[TBL] [Abstract][Full Text] [Related]
16. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.
Peach RJ; Bajorath J; Brady W; Leytze G; Greene J; Naemura J; Linsley PS
J Exp Med; 1994 Dec; 180(6):2049-58. PubMed ID: 7964482
[TBL] [Abstract][Full Text] [Related]
17. Synergistic induction of CTLA-4 expression by costimulation with TCR plus CD28 signals mediated by increased transcription and messenger ribonucleic acid stability.
Finn PW; He H; Wang Y; Wang Z; Guan G; Listman J; Perkins DL
J Immunol; 1997 May; 158(9):4074-81. PubMed ID: 9126965
[TBL] [Abstract][Full Text] [Related]
18. CD28 engagement by B7/BB-1 induces transient down-regulation of CD28 synthesis and prolonged unresponsiveness to CD28 signaling.
Linsley PS; Bradshaw J; Urnes M; Grosmaire L; Ledbetter JA
J Immunol; 1993 Apr; 150(8 Pt 1):3161-9. PubMed ID: 7682233
[TBL] [Abstract][Full Text] [Related]
19. A native soluble form of CTLA-4.
Oaks MK; Hallett KM; Penwell RT; Stauber EC; Warren SJ; Tector AJ
Cell Immunol; 2000 May; 201(2):144-53. PubMed ID: 10831323
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and expression of feline CD28 and CTLA-4 cDNA.
Choi IS; Hash SM; Collisson EW
Vet Immunol Immunopathol; 2000 Aug; 76(1-2):45-59. PubMed ID: 10973685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
